Clinical Trial Update: SonoVue®-Enhanced Ultrasound (US) Versus Unenhanced US for Focal Liver Lesion Characterization [Phase 3]

View source ↗

Summary

Phase 3 trial comparing SonoVue-enhanced ultrasound to unenhanced ultrasound for focal liver lesion characterization has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Neoplasms

Drugs mentioned

• SonoVue (sulfur hexafluoride microbubbles)

Snippet

Sponsor: Bracco Diagnostics, Inc | Conditions: Liver Neoplasms | Phase 3 | Status: COMPLETED | Results posted: 2018-08-03